Steve Beuchaw
Stock Analyst at Morgan Stanley
(2.39)
# 2,529
Out of 4,974 analysts
98
Total ratings
58.46%
Success rate
6.33%
Average return
Main Sectors:
Stocks Rated by Steve Beuchaw
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Downgrades: Equal-Weight | $52 → $49 | $47.55 | +3.97% | 2 | Jan 6, 2025 | |
| A Agilent Technologies | Initiates: Outperform | n/a | $128.75 | - | 20 | Dec 13, 2023 | |
| ALGN Align Technology | Maintains: Outperform | $711 → $770 | $139.12 | +453.48% | 11 | Jul 29, 2021 | |
| BRKR Bruker | Upgrades: Peer Perform | n/a | $30.83 | - | 9 | Nov 16, 2020 | |
| HSIC Henry Schein | Upgrades: Outperform | $68 | $69.45 | -2.09% | 4 | Apr 2, 2020 | |
| XRAY DENTSPLY SIRONA | Upgrades: Outperform | $66 | $14.62 | +351.44% | 6 | Apr 2, 2020 | |
| ILMN Illumina | Maintains: Equal-Weight | $320 → $288 | $98.93 | +191.11% | 9 | Jan 7, 2019 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $254 → $260 | $492.60 | -47.22% | 7 | Oct 25, 2018 | |
| WAT Waters | Maintains: Equal-Weight | $204 → $211 | $306.32 | -31.12% | 13 | Oct 10, 2018 | |
| MYGN Myriad Genetics | Maintains: Overweight | $51 → $54 | $6.61 | +716.94% | 10 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $21 → $41 | $168.02 | -75.60% | 5 | Sep 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $335 | $295.43 | +13.39% | 1 | Sep 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $335 | $294.60 | +13.71% | 1 | Sep 20, 2018 |
Qiagen
Jan 6, 2025
Downgrades: Equal-Weight
Price Target: $52 → $49
Current: $47.55
Upside: +3.97%
Agilent Technologies
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $128.75
Upside: -
Align Technology
Jul 29, 2021
Maintains: Outperform
Price Target: $711 → $770
Current: $139.12
Upside: +453.48%
Bruker
Nov 16, 2020
Upgrades: Peer Perform
Price Target: n/a
Current: $30.83
Upside: -
Henry Schein
Apr 2, 2020
Upgrades: Outperform
Price Target: $68
Current: $69.45
Upside: -2.09%
DENTSPLY SIRONA
Apr 2, 2020
Upgrades: Outperform
Price Target: $66
Current: $14.62
Upside: +351.44%
Illumina
Jan 7, 2019
Maintains: Equal-Weight
Price Target: $320 → $288
Current: $98.93
Upside: +191.11%
Thermo Fisher Scientific
Oct 25, 2018
Maintains: Overweight
Price Target: $254 → $260
Current: $492.60
Upside: -47.22%
Waters
Oct 10, 2018
Maintains: Equal-Weight
Price Target: $204 → $211
Current: $306.32
Upside: -31.12%
Myriad Genetics
Oct 10, 2018
Maintains: Overweight
Price Target: $51 → $54
Current: $6.61
Upside: +716.94%
Sep 28, 2018
Maintains: Overweight
Price Target: $21 → $41
Current: $168.02
Upside: -75.60%
Sep 20, 2018
Initiates: Equal-Weight
Price Target: $335
Current: $295.43
Upside: +13.39%
Sep 20, 2018
Initiates: Equal-Weight
Price Target: $335
Current: $294.60
Upside: +13.71%